10mg vial of retatrutide (10mg) – Vitanx Research Buy Retatrutide | 10 mg

Cardiovascular benefits The SELECT trial a landmark cardiovascular outcomes study involving over 17,000 participants showed that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity who did not have diabetes

If approval occurs, switching guidance will emerge from prescribing information and clinical experience

A.EdwardsC

doi: 10.1056/NEJMoa1612917 81 RuffCTBaronMImKODonoghueMLFiedorekFTSabatineMS

Concerningly, retatrutide also activates glucagon receptors, which can impact blood sugar levels

Each positive trial result moves the molecule closer to NDA submission